| Genomic Medicine |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Beta-Thalassemia |
0 |
0.98 |
| Thalassemia |
0 |
0.47 |
| Stem Cell Research and Therapy |
0 |
0.46 |
| Sickle Cell Anemia |
0 |
0.43 |
| Blood Transfusion |
0 |
0.34 |
| Gene Therapy |
0 |
0.97 |
| Transfusion |
0 |
0.31 |
| CRISPR |
0 |
0.3 |
| Lysosomal Storage Disease |
0 |
0.3 |
| Gene Editing |
0 |
0.26 |
| Blood |
0 |
0.25 |
| I-Cell Disease |
0 |
0.25 |
| Renal Failure |
0 |
0.24 |
| Bone Marrow Transplant |
0 |
0.23 |
| Leukemia |
0 |
0.22 |
| Transplantation |
0 |
0.22 |
| Cell Transplantation |
0 |
0.18 |
| Pain Management |
0 |
0.17 |
| Child |
0 |
0.16 |
| Hemoglobin |
0 |
0.16 |
| Bone Marrow |
0 |
0.13 |
| Pediatric Transplantation |
0 |
0.13 |
| Toxicology |
0 |
0.13 |
| Revenue and Practice Management |
0 |
0.12 |
| Allograft |
0 |
0.11 |
| Bone |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Genetic Disorders |
0 |
0.07 |
| Europe |
0 |
0.06 |
| Genetics |
0 |
0.06 |